In the post-PIP era, the medical aesthetics industry can expect to be dogged by issues of trust and quality. Rosalind Hill speaks to Douglas Ingram about how Allergan plans to address these questions head-onRead More
PRIME Journal is part of the Informa Markets Division of Informa PLC
PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.